Research Topics
Species | Shrikant AnantSummaryAffiliation: University of Kansas Medical Center Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Prevention of colitis-associated cancer: natural compounds that target the IL-6 soluble receptorCate Moriasi
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
Anticancer Agents Med Chem 12:1221-38. 2012....
Nanoparticle-based delivery of siDCAMKL-1 increases microRNA-144 and inhibits colorectal cancer tumor growth via a Notch-1 dependent mechanismSripathi M Sureban
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma 73104, USA
J Nanobiotechnology 9:40. 2011..To measure let-7a and miR-144 expression in vitro, HCT116 cells were transfected with plasmids encoding the firefly luciferase gene with let-7a and miR-144 miRNA binding sites in the 3'UTR...
Honokiol radiosensitizes colorectal cancer cells: enhanced activity in cells with mismatch repair defectsZhiyun He
Department of Medicine, Lanzhou University Second Hospital, Gansu Province, China
Am J Physiol Gastrointest Liver Physiol 301:G929-37. 2011..These data demonstrate that honokiol is highly effective in radiosensitizing colorectal cancer cells, especially those with a mismatch repair defect...
CDK-4 inhibitor P276 sensitizes pancreatic cancer cells to gemcitabine-induced apoptosisDharmalingam Subramaniam
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Mol Cancer Ther 11:1598-608. 2012..Taken together, these data suggest that P276-Gem combination is a novel potent therapeutic agent that can target the Akt-mTOR signaling pathway to inhibit both tumor growth and angiogenesis...
RNA binding protein CUGBP2/CELF2 mediates curcumin-induced mitotic catastrophe of pancreatic cancer cellsDharmalingam Subramaniam
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas, United States of America
PLoS ONE 6:e16958. 2011..Here, we have determined that curcumin modulates the expression of RNA binding protein CUGBP2 to inhibit pancreatic cancer growth...
3,5-bis(2,4-difluorobenzylidene)-4-piperidone, a novel compound that affects pancreatic cancer growth and angiogenesisDharmalingam Subramaniam
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, KS 66160, USA
Mol Cancer Ther 10:2146-56. 2011..Taken together, these data suggest that DiFiD is a novel potent therapeutic agent that can target different aspects of the Notch signaling pathway to inhibit both tumor growth and angiogenesis...
Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cellsGaurav Kaushik
Department of Surgery, University of Kansas Medical Center, Kansas City, KS, USA
Am J Surg 204:868-73. 2012..Therefore, developing new therapies with low toxicity is of utmost importance. Honokiol is a natural compound that recently has shown promise as an effective anticancer agent...
Honokiol in combination with radiation targets notch signaling to inhibit colon cancer stem cellsSivapriya Ponnurangam
Department of Molecular and Integrative Physiology, The University of Kansas Medical Center, Kansas City, Kansas 66160, USA
Mol Cancer Ther 11:963-72. 2012..These studies warrant further clinical evaluation for the combination of honokiol and IR for treating colon cancers...
Critical roles of Notch and Wnt/β-catenin pathways in the regulation of hyperplasia and/or colitis in response to bacterial infectionIshfaq Ahmed
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas, USA
Infect Immun 80:3107-21. 2012..Thus, the balancing act between cell proliferation and mucus production to restore barrier integrity seems to depend upon the interplay between the Wnt/β-catenin and Notch pathways in the TMCH model...
Curcumin induces cell death in esophageal cancer cells through modulating Notch signalingDharmalingam Subramaniam
Department of Molecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Kansas, United States of America
PLoS ONE 7:e30590. 2012..Here, we have determined that curcumin inhibits esophageal cancer growth via a mechanism mediated through the Notch signaling pathway...
Research Grants
- Dietary Prevention of CancerShrikant Anant; Fiscal Year: 2007..Together these studies should provide insight into the cancer process and how curcumin suppresses the risk and proliferation of colon cancer, and of no less importance, why curcumin is of great value as a food supplement. ..
- RNA Binding Protein CUGBP2 in Intestinal EpitheliumShrikant Anant; Fiscal Year: 2010..We are in the process of identifying how the gene expressing CUGBP2 is silenced in cancer cells so that we can determine ways to reverse the process. This might stop or slow down the tumorigenesis. ..
- Dietary Prevention of CancerShrikant Anant; Fiscal Year: 2010..We expect that the work will lead to a better understanding of the tumorigenesis process and identify novel methods to stop or slow down tumorigenesis. ..
- RNA Binding Proteins in CancerShrikant Anant; Fiscal Year: 2010..We expect that the work will lead to a better understanding of the tumorigenesis process which should subsequently lead to novel methods to stop or slow down tumorigenesis. ..
- Dietary Prevention of CancerShrikant Anant; Fiscal Year: 2010..We expect that the work will lead to a better understanding of the tumorigenesis process and identify novel methods to stop or slow down tumorigenesis. ..
